We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Guys we are already valued at £60m based on £4m for 2020 and forecast £10m for 2021. The market will change the share price when guidance for 2021 is updated which will be very soon. Not long now.
I have asked myself the same question Diversified. I have come to the conclusion that the market doesn't know what aspect of our portfolio to focus on. In other words I am not sure they know what we do! This is by no means a criticism of DeepVerge, I have a healthy stake invested and I am comfortably in profit so the market has taken notice over the past 12 months or so, but the potential here is staggering. Skintrust, Water Monitoring and Breath Test could all be stand-alone businesses and I could see these becoming spin-offs at some stage, akin to what Open Orphan are doing. For me, any deal with China Resources is going to put a marker down, almost as if to say 'here we are come and see what else we have'. This deal could be the catalyst that joins the dots for investors or Institutions currently with a watching brief and we could see some heavy buying. Keep an eye on Microsaic as they will also benefit if DeepVerge go stratospheric. This is a very exciting company to be invested in.
I honestly can’t understand why this company is so under the radar in terms of expectation in comparison to others.
- Mou/JV/Modern water
A complete under reaction in the share price to what can be a game changing outcome in its own right. Why has the market not reacted to this and rerated the stock in expectation of news that could come as soon as the 30th June. Referred to as a non dilutive and possible end point with a Hong Kong listing, implying a way to monetize an asset. With this and prospects inside and outside of Europe.
- Breath test
Results referred to as imminent, with high sensitivity and specificity like no other with results in seconds. It can transform our present environment in a number of attractive settings.
- skincare
Generating significant revenue on a major growth trajectory.
To have raised the money at a relatively low discount to market price and to be sitting within a strong technical pattern that could see a major breakout and momentum. I honestly can’t understand why this hasn’t already turned the markets head in a major way.
Sterghios A. Moschos
@DocMoschos
"Watch this space. Data is now imminent."
https://twitter.com/docmoschos/status/1406151049380085761?s=21